Universal Health Services, Inc.

The forensic scores point in different directions and should be read together. The Beneish M-Score is -2.453, which its label places below -1.78 and not in the elevated manipulation-risk zone. That is a screening result, meaning the accounting patterns it measures do not trigger a flag, not a guarantee that the reported numbers are accurate. The Altman Z″-Score of 3.54 falls in the safe zone under its label. The Piotroski F-Score is 7 of 8 computable signals, meaning seven of the eight signals that could be computed were favorable. Operating cash flow of $1.86 billion was 1.25 times net income of $1.49 billion, a healthy ratio, but operating cash flow declined about 10% from 2024, so earnings grew faster than cash generation in 2025. Long-term debt fell to $4 billion from $4.46 billion, yet the 2026 Notes are a near-term refinancing event that management says will raise interest expense. Readers may want to look at how the company's Medicaid program revenues, which it says are mostly approved on a year-to-year basis, and the estimated $432 million to $480 million reduction by 2032 show up in future filings. The filings describe a larger and more profitable company whose balance sheet and cash-flow screens look sound, but whose outlook for 2026 and later depends heavily on federal and state policy decisions outside its control.

Catalyst.Revenue rose to $17.36 billion in 2025 from $15.83 billion in 2024, growth of 9.7%. Operating income increased to $1.99 billion from $1.68 billion, and net income rose to $1.49 billion from $1.14 billion. The 10-K describes two main segments, acute care hospitals and behavioral health care facilities, with 375 inpatient facilities and 168 outpatient and other facilities across 40 states, Washington, D.C., the United Kingdom and Puerto Rico. UK behavioral health facilities generated net revenues of approximately $1.001 billion in 2025, up from $880 million in 2024, making the UK operations a visible contributor to recent growth.

Hidden risk.The most material tension is policy exposure. The July 4, 2025 One Big Beautiful Bill Act adds Medicaid work requirements and limits provider fees, which the company estimates will reduce its aggregate annual net benefit by approximately $432 million to $480 million by 2032. Enhanced ACA premium tax credits expired on December 31, 2025, and no extension had been enacted as of early May 2026. Separately, $700 million of 1.65% senior notes mature on September 1, 2026, and management expects refinancing at significantly higher rates. Operating cash flow also fell to $1.86 billion in 2025 from $2.07 billion in 2024.